TJ

The Journal of Infectious Diseases

The Journal of Infectious Diseases is an Oxford Academic journal affiliated with the Infectious Diseases Society of America that publishes research and commentary in infectious diseases and offers both subscription access and optional open access publishing.

Looking to publish in The Journal of Infectious Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Impact Factor 4.5
Quartile Q2
Open Access Type Hybrid
ISSN 0022-1899
eISSN 1537-6613
Invitation Only No
Cost Range Standard license: no license charge. OA article processing charge: $5,001. Page composition charges: $125 per finished typeset page.

Submission Instructions

The Journal of Infectious Diseases accepts the following article types. Click on an article type to view submission instructions.

Major Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required and must be provided as the second page of the manuscript. Abstract must be no more than 250 words. Abstract must be structured. Abstract must use the headings Background, Methods, Results, and Conclusions.
Manuscript Major Articles must not exceed 3500 words. Manuscript must include a Methods section detailed enough to allow readers to repeat the study without referring to supplementary material. Title page must include a 40-word summary of the article’s main point.
References Major Articles are limited to 40 references. References must be numbered consecutively as they appear in the text, with the numbers in brackets on the text line.
Figures & Tables Major Articles are limited to 7 figures and tables combined. Tables must be on separate pages. Tables and figures must be numbered consecutively by appearance, each table must have a legend or title, and each figure must have a legend.
Reformat to The Journal of Infectious Diseases using Livewrite Premium

Brief Reports

Cover Letter Cover Letter requirements are not specified.
Abstract Brief Reports must include an abstract. The abstract must be unstructured and must not exceed 100 words. The abstract must be unstructured.
Manuscript Brief Reports must not exceed 1500 words. The text must be ordered as Background, Methods, Results, and Discussion. The methods section must be sufficiently detailed to allow readers to repeat the study without referring to supplementary material.
References Brief Reports are limited to 15 references. References must be numbered consecutively as they appear in the text, with the numbers in brackets on the text line.
Figures & Tables Brief Reports are limited to 2 figures and tables combined. Tables must be on separate pages.
Reformat to The Journal of Infectious Diseases using Livewrite Premium

Correspondence

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract requirements are not specified.
Manuscript Manuscript must not exceed 750 words. Correspondence must respond to an article published in the journal within the preceding 12 months and be prepared in manuscript format including a title page.
References References are limited to 10. References must be numbered consecutively as they appear in the text, with the numbers in brackets on the text line.
Figures & Tables Correspondence is limited to 1 figure or table. Tables must be on separate pages. Tables and figures must be numbered consecutively by appearance, and each table or figure must include a legend or title.
Reformat to The Journal of Infectious Diseases using Livewrite Premium

Recent Publications

Evaluation of Three Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccines RSV/ΔNS2/Δ1313/I1314L, RSV/6120/ΔNS2/1030s, and RSV/276 in RSV Seronegative Children

Coleen K Cunningham, Ruth A Karron, Elizabeth J McFarland, Mark J Giganti, Rachel Ketchum, Charlotte Perlowski, Jennifer Libous, Haley Brozik, Jennifer Oliva, Dwight E Yin, Patrick Jean-Philippe, Jack Moye, Elizabeth Schappell, Emily A Barr, Vivian Rexroad, Benjamin Johnston, Grace Malonga, Mariam Aziz, Tori Rutherford, Heidi Sallee, Jennifer Jao, Robert W Frenck, Jaime G Deville, Emmanuel B Walter, James Christopher Day, Stephen A Spector, Andrés Camacho-Gonzalez, Joanna Dobroszycki, Sharon Nachman, Mary E Paul, James Campbell, Xueqiao Liu, Lijuan Yang, Cindy Luongo, Peter L Collins, Ursula J Buchholz

10.1093/infdis/jiag489
View Publication

The host transcriptional response to real-world cryptococcosis in the setting of advanced HIV disease defines dysregulated immune responses that underlie increased vulnerability to infection

Beatrice Z Sim, Julie M Steinbrink, Cameron Miller, Alejandro Antonia, J Andrew Alspaugh, Deng B Madut, Manuela Carugati, John A Crump, Blandina T Mmbaga, James S Ngocho, Asia H Kipengele, Philoteus A Sakasaka, Nathaniel H Kalengo, Venance P Maro, Matthew P Rubach, Micah T McClain

10.1093/infdis/jiag497
View Publication

Population-level shift in ex vivo artemisinin susceptibility in Plasmodium falciparum : comparison of 2014–2015 and 2022–2024 surveys in northern Uganda

Mie Ikeda, Betty Balikagala, Naoko Yoshida, Megumi Kaneko-Ogawa, Jun Hirata, Makoto Hirai, Osbert T Katuro, Makoto Kubo, Naoyuki Fukuda, Miki Sakurai-Yatsushiro, Dennis A Anywar, Emmanuel I Odongo-Aginya, David M Ogwang, Nirianne M Q Palacpac, Toshihiro Horii, Toshihiro Mita

10.1093/infdis/jiag494
View Publication

Low birthweight and prematurity, but not malaria chemoprevention, are associated with reduced pneumococcal vaccine immunogenicity in Ugandan infants

Kenneth Musinguzi, Alyssa N Sbarra, Florian Bach, Felistas Nankya, Karen Bino Achom, Caroline Mwubaha, Patience Nayebare, Evelyn Nansubuga, Abel Kakuru, Jimmy Kizza, Zedekiah Maato, Emmanuel Arinaitwe, Kathleen Dantzler Press, Bernard Ssentalo Bagaya, Stephen Tukwasibwe, Isaac Ssewanyana, Joaniter Immaculate Nankabirwa, Moses Robert Kamya, Grant Dorsey, Saki Takahashi, Prasanna Jagannathan

10.1093/infdis/jiag488
View Publication

Carbapenemase-producing Kluyvera spp.: epidemiology of an evolving species

Gabrielle D Levi, Mor N Lurie-Weinberger, David Schwartz, Meirav Mor, Shmuel Benenson, Marc V Assous, Haim Ben-Zvi, Antoine Andremont, Alona Keren-Paz, Yehuda Carmeli

10.1093/infdis/jiag468
View Publication

Frequently asked questions

How long does it take to publish?

A review pathway is offered for papers previously peer reviewed at another medical journal to speed publication and minimize unnecessary re-review.

Reformat to The Journal of Infectious Diseases using Livewrite Premium

Is a cover letter required?

Cover letters are not required. The submission system collects the information previously provided in cover letters, including a brief pitch. A cover letter explanation is needed if an alternative control was used in experiments involving genetically engineered mice.

Reformat to The Journal of Infectious Diseases using Livewrite Premium

What are the publication costs?

Research Topics

HIV Research and Treatment Respiratory viral infections research Viral gastroenteritis research and epidemiology Herpesvirus Infections and Treatments Cytomegalovirus and herpesvirus research HIV/AIDS Research and Interventions Pneumonia and Respiratory Infections Influenza Virus Research Studies Hepatitis B Virus Studies Viral Infections and Vectors HIV/AIDS drug development and treatment Mosquito-borne diseases and control Bacterial Infections and Vaccines Mycobacterium research and diagnosis Hepatitis C virus research Malaria Research and Control Antimicrobial Resistance in Staphylococcus Reproductive tract infections research Immune Cell Function and Interaction Streptococcal Infections and Treatments Immune Response and Inflammation Tuberculosis Research and Epidemiology Escherichia coli research studies Virology and Viral Diseases Diverse Scientific and Economic Studies